Group One Trading, L.P. Atai Life Sciences N.V. Transaction History
Group One Trading, L.P.
- $2.81 Billion
- Q3 2025
A detailed history of Group One Trading, L.P. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Group One Trading, L.P. holds 600,507 shares of ATAI stock, worth $2.4 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
600,507
Previous 37,753
1490.62%
Holding current value
$2.4 Million
Previous $82,000
3773.17%
% of portfolio
0.11%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ATAI
# of Institutions
149Shares Held
45.8MCall Options Held
1.88MPut Options Held
543K-
Ubs Group Ag7.68MShares$30.7 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$21.7 Million0.05% of portfolio
-
Morgan Stanley New York, NY4.82MShares$19.3 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.58MShares$10.3 Million0.0% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY2.29MShares$9.15 Million12.47% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $664M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...